  The new coronavirus disease 2019 (COVID-19) has been emerged as a rapidly
spreading pandemic. The disease is thought to spread mainly from
person-to-person through respiratory droplets produced when an infected person
coughs, sneezes, or talks. The pathogen of COVID-19 is the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). It infects the cells binding
to the angiotensin-converting enzyme 2 receptor (ACE2) which is expressed by
cells throughout the airways as targets for cellular entry. Although the
majority of persons infected with SARS-CoV-2 experience symptoms of mild upper
respiratory tract infection, in some people infections of the peripheral
airways result in severe, potentially fatal pneumonia. However, the induction
of COVID-19 pneumonia requires that SARS-CoV-2 reaches the peripheral airways.
While huge efforts have been made to understand the spread of the disease as
well as the pathogenesis following cellular entry, much less attention is paid
how SARS-CoV-2 from the environment reach the receptors of the target cells.
The aim of the present study is to characterize the deposition distribution of
SARS-CoV-2 in the airways upon exposure to cough-generated aerosol. For this
purpose, the Stochastic Lung Deposition Model has been applied. Aerosol size
distribution and breathing parameters were taken from the literature supposing
normal breathing through the nose. We found that the probability of direct
infection of the peripheral airways due to inhalation of aerosol generated by a
bystander cough is very low. As the number of pathogens deposited in the
extrathoracic airways is ~10 times higher than in the peripheral airways, we
concluded that in most cases COVID-19 pneumonia must be preceded by SARS-CoV-2
infection of the upper airways. Our results suggest that without the
enhancement of viral load in the upper airways, COVID-19 would be much less
dangerous...
